G-CSF-primed bone marrow cells for autologous transplantation

Early-childhood temperament deviations mark psychiatric risk into early adulthood.

medRxiv : the preprint server for health sciences·2026

First Results on the Search for Lepton Number Violating Neutrinoless Double-β Decay with the LEGEND-200 Experiment.

Physical review letters·2026

Contribution of post-infectious bronchiolitis obliterans to non-cystic fibrosis bronchiectasis in children.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025

An analysis of referral patterns of traumatic brain injury at Groote Schuur Hospital Trauma Centre.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2024

Abundant pleiotropy across neuroimaging modalities identified through a multivariate genome-wide association study.

Nature communications·2024

Assessing the Risk of Hypoglycemia Secondary to Propranolol Therapy for the Treatment of Supraventricular Tachycardia in Infants.

Pediatric cardiology·2023

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Retraction: Bone marrow mesenchymal stem cells alleviate smoke inhalation injury by regulating alveolar macrophage polarization via the CD200-CD200R pathway.

Frontiers in immunology·2026

Splenic neuromodulation as monotherapy and in combination with biologic or targeted synthetic DMARDs for difficult-to-treat rheumatoid arthritis (ConsiderRAte): a randomised, sham-controlled, early feasibility trial.

EClinicalMedicine·2026

Predictors of Treatment Failure and Second-Line Therapy Outcomes After Rezūm Therapy for Benign Prostatic Hyperplasia.

Cureus·2026

Development of tetrahydroquinazoline compounds as Fusion protein inhibitors for the treatment of respiratory syncytial virus.

European journal of medicinal chemistry·2026

From 18F‑MC225 to Conformationally Free Derivatives.

ACS omega·2026

Storage-associated physicochemical changes in extracellular vesicles derived from human mesenchymal stromal cells.

Frontiers in bioengineering and biotechnology·2026

Related Experiment Videos

G-CSF-primed bone marrow cells for autologous transplantation

Related Concept Videos

Early-childhood temperament deviations mark psychiatric risk into early adulthood.

First Results on the Search for Lepton Number Violating Neutrinoless Double-β Decay with the LEGEND-200 Experiment.

Contribution of post-infectious bronchiolitis obliterans to non-cystic fibrosis bronchiectasis in children.

An analysis of referral patterns of traumatic brain injury at Groote Schuur Hospital Trauma Centre.

Abundant pleiotropy across neuroimaging modalities identified through a multivariate genome-wide association study.

Assessing the Risk of Hypoglycemia Secondary to Propranolol Therapy for the Treatment of Supraventricular Tachycardia in Infants.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Retraction: Bone marrow mesenchymal stem cells alleviate smoke inhalation injury by regulating alveolar macrophage polarization via the CD200-CD200R pathway.

Splenic neuromodulation as monotherapy and in combination with biologic or targeted synthetic DMARDs for difficult-to-treat rheumatoid arthritis (ConsiderRAte): a randomised, sham-controlled, early feasibility trial.

Predictors of Treatment Failure and Second-Line Therapy Outcomes After Rezūm Therapy for Benign Prostatic Hyperplasia.

Development of tetrahydroquinazoline compounds as Fusion protein inhibitors for the treatment of respiratory syncytial virus.

From 18F‑MC225 to Conformationally Free Derivatives.

Storage-associated physicochemical changes in extracellular vesicles derived from human mesenchymal stromal cells.

Related Experiment Videos

G-CSF-primed bone marrow cells for autologous transplantation

Related Concept Videos

Related Articles